Apolipoprotein B assessment for evaluating lipid goals


Tekiner E., Oguz A. , Uzunlulu M. , Tekiner F.

ACTA CARDIOLOGICA, vol.66, no.4, pp.433-438, 2011 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 66 Issue: 4
  • Publication Date: 2011
  • Doi Number: 10.2143/ac.66.4.2126590
  • Title of Journal : ACTA CARDIOLOGICA
  • Page Numbers: pp.433-438

Abstract

Objective It is suggested that the apolipoprotein (Apo) B levels are more valuable than LDL cholesterol (LDL-C) levels in assessing cardiovascular risk associated with hyperlipidaemia. However, although non-HDL cholesterol (non-HDL-C) levels are accepted as a secondary objective after achieving LDL-C levels in the guidelines, Apo B has not been recommended as a therapeutic goal yet. The objective of this study was to determine how many of the patients who achieved the LDL-C and non-HDL-C target recommended by the guidelines with a statin therapy achieved the Apo B target.